搜尋結果
China is aligning its regulatory environment with that of global standards with an aim to promote innovation, simplify drug development processes and to enhance the efficacy, quality and safety of the drugs approved. Read this whitepaper to learn how LifeSphere Safety MultiVigilance (ARISc), the drug safety software.
- Challenges For Many South Korean Cros
- The State of Pharmacovigilance Regulation Updates in South Korea
- Cros and Service Providers Are at A Crossroads
Traditional safety workflows are inefficient, labor-intensive, and contain multiple manual, time-consuming steps. They are also cost-effective to scale, which makes it difficult to stay cost-competitive and efficiently deliver the level of service that clients expect (or demand). To grow a serviceable market, CROs and service providers need to meet...
Globally, pharmacovigilance regulations are constantly changing in terms of analyzing safety information worldwide. Increasing demand and industry competition, partnered with complex regulations and global operations makes for a complex landscape to navigate. Since South Korea became a member of the International Council for Harmonisation(ICH) in 2...
Today we are finding that globally, CROs and service providers are at a breaking point. According to industry biopharma trend reports, big pharma companies are currently outsourcing 40-45% of their activities, which is projected to grow to 60% and the outsourcing market is set to grow to $91.4B by 2028 to meet rising demands. In turn, many CROs, an...
Speak to an ArisGlobal representative today about the groundbreaking edge that LifeSphere Clarity can provide for your organization. Discover the new frontier in safety signal analytics with LifeSphere Clarity and unlock new insights within your safety data.
ArisGlobal is trusted by hundreds of clients around the world including: Contract research organizations (CROs) and service providers. Enterprise pharmaceutical and biotech companies. Small to medium pharmaceutical and biotech companies. Regulatory agencies, including the FDA. Learn how we can support your team. Partnering to advance the industry.
A thirty-year veteran of the life sciences R&D software industry that counts 30 of the top 50 global biopharma companies and six global health authorities – including the US FDA – among its customer base, ArisGlobal’s growth is fueled by a trend toward digital transformation within life sciences companies.
2024年2月1日 · Boston, Massachusetts, USA – February 1, 2024 – ArisGlobal, a leading innovative life sciences technology company and creator of LifeSphere®, today announced the formal charter for the new GenAI Council, which will sit for the first time this month. The global Council is a small and exclusive top-tier group of AI tech, academia ...
ArisGlobal’s LifeSphere LitPro application is a full-service automated literature screening and monitoring solution designed to help life sciences organizations meet regulatory compliance requirements by scanning global and local literature databases for safety-relevant information including products, adverse events, medical terms, and investiga...
&ck=589B7961EEA9AF833349E3EDACE934C0&idpp=rc&idpview=singleimage&form=rc2idp "張學雷女兒1")
&ck=C6049C2B6481AA0DCE2D588264A75080&idpp=rc&idpview=singleimage&form=rc2idp "張學雷女兒2")
&ck=9611F708DD980CCD72BF121B1E8317AD&idpp=rc&idpview=singleimage&form=rc2idp "張學雷女兒3")
&ck=BAD9C1CBE7B85ED63430E555F1DE628F&idpp=rc&idpview=singleimage&form=rc2idp "張學雷女兒4")
&ck=3A9605E9DEE5FA0931FAB76BB406E62D&idpp=rc&idpview=singleimage&form=rc2idp "張學雷女兒5")
